Publications by authors named "Erin Twohy"

Claim this Profile
P
Phase 1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma: A Clinical Trial Protocol.
Andres Ramos-Fresnedo, Rawan Al-Kharboosh, Erin L Twohy, Aleeshba N Basil, Ewa C Szymkiewicz

Neurosurg Pract· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas.
Priscilla K Brastianos, Erin Twohy, Susan Geyer, Elizabeth R Gerstner, Timothy J Kaufmann

N Engl J Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of circulating markers with cognitive decline after radiation therapy for brain metastasis.
Kristin Huntoon, S Keith Anderson, Karla V Ballman, Erin Twohy, Katharine Dooley

Neuro Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mayo-PACC: A parsimonious preclinical Alzheimer's disease cognitive composite comprised of public-domain measures to facilitate clinical translation.
Nikki H Stricker, Erin L Twohy, Sabrina M Albertson, Aimee J Karstens, Walter K Kremers

Alzheimers Dement· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic Mutations.
Priscilla K Brastianos, Erin L Twohy, Elizabeth R Gerstner, Timothy J Kaufmann, A John Iafrate

J Clin Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mayo normative studies: A conditional normative model for longitudinal change on the Auditory Verbal Learning Test and preliminary validation in preclinical Alzheimer's disease.
Eva C Alden, Emily S Lundt, Erin L Twohy, Teresa J Christianson, Walter K Kremers

Alzheimers Dement (Amst)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance).
Evanthia Galanis, S Keith Anderson, Erin Twohy, Nicholas A Butowski, Adilia Hormigo

Neurooncol Adv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial.
Karyn A Goodman, Fang-Shu Ou, Nathan C Hall, Tanios Bekaii-Saab, Briant Fruth, Erin Twohy

J Clin Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872.
Evanthia Galanis, S Keith Anderson, Erin L Twohy, Xiomara W Carrero, Jesse G Dixon

Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).
Kurt A Jaeckle, S K Anderson, Erin L Twohy, Jesse G Dixon, Caterina Giannini

J Neurooncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).
Kurt A Jaeckle, S K Anderson, Erin L Twohy, Jesse G Dixon, Caterina Giannini

J Neurooncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572.
David Schiff, Kurt A Jaeckle, S Keith Anderson, Evanthia Galanis, Caterina Giannini, Erin Twohy

Cancer· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial.
Thomas M Churilla, Karla V Ballman, Paul D Brown, Erin L Twohy, Kurt Jaeckle

Int J Radiat Oncol Biol Phys· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis